Handelsavisen
prelaunch
Companies Healthcare 3183.T
31
3183.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

Win-Partners Co Ltd

¥1 216,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
4,11 %
Op margin
3,4 %
ROE
8,4 %
Net margin
2,5 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Win-Partners Co Ltd operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. Win-Partners Co Ltd (3183.T) is a Japanese company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on the sale of medical products. Headquartered in Japan, the company is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
8,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 3183.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 3183.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Win-Partners Co Ltd (3183.T) is a Japanese company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on the sale of medical products. Headquartered in Japan, the company is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Win-Partners Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to ¥16,209,529,000, representing 34.8% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The current ratio of 1.86 suggests the company has sufficient short-term assets to cover its short-term liabilities.

    Profitability metrics show a return on equity (ROE) of 8.39% and a return on assets (ROA) of 4.33%. These figures are in line with the industry's typical performance, as the company generates operating income of ¥2,808,403,000 and net income of ¥2,019,053,000 on total revenue of ¥81,410,300,000. The gross profit margin is 12.15%, which is consistent with the industry's cost structure.

    The company's revenue is not segmented by geographic region or product line in the available data, but the absence of disclosed geographic or segment breakdown suggests a relatively concentrated business model. The company's operations are likely centered in Japan, given the JPY-based financials and the lack of international revenue disclosure.

    Looking ahead, the company's revenue is expected to remain stable, with no significant growth or decline indicated in the outlook. The operating cash flow of ¥2,058,003,000 and free cash flow of ¥359,532,000 support the company's ability to fund operations and potentially invest in future growth. The capital expenditure of -¥463,065,000 indicates a reduction in capital spending, which may reflect a strategic shift or a focus on optimizing existing assets.

    Risk factors for Win-Partners Co Ltd are currently low, with no immediate liquidity or dilution flags detected. The company's low debt levels and strong cash position reduce financial risk. Additionally, the absence of dilution risk suggests that the company is not planning to issue new shares in the near term, preserving shareholder value.

    Recent financial filings and transcripts do not indicate any major events or strategic changes for Win-Partners Co Ltd. The company's financial performance and operational strategy appear to be stable, with no significant disruptions reported in the latest available data.

    Key takeaways
    • Win-Partners Co Ltd has a strong liquidity position with no long-term debt and a current ratio of 1.86.
    • The company's profitability metrics, including ROE of 8.39% and ROA of 4.33%, are in line with industry norms.
    • The company's revenue is not segmented by geographic region or product line, suggesting a relatively concentrated business model.
    • The company's capital expenditure has decreased, indicating a potential strategic shift or focus on optimizing existing assets.
    • Win-Partners Co Ltd has no immediate liquidity or dilution risks, preserving shareholder value.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥1 216,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥24.07B
    Net cash
    ¥16.21B
    Current ratio
    1.9
    Debt / equity
    0.0
    ROA
    4.3%
    ROE
    8.4%
    Cash conversion
    102.0%
    CapEx / revenue
    -0.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin3,5 %Below median
    Net Margin2,5 %Below median
    ROE8,4 %Above P75
    Capex / Rev-0,6 %Above P75
    D/E0,00Above P75
    Cash Conv1,02Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Win-Partners Co Ltd Market data — financials · 2026-05-26
    • Win-Partners Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    3183.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage